WILMINGTON, DE — Incyte (Nasdaq: INCY) announced plans to participate in several investor conferences throughout September 2025.
The company will present at the Cantor Global Healthcare Conference on September 3 at 8:00 a.m. EDT, followed by the Wells Fargo Healthcare Conference on September 4 at 8:45 a.m. EDT. Incyte will also speak at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9 at 10:00 a.m. EDT.
The presentations will be webcast live via Incyte’s investor website and available for replay for 30 days.
Headquartered in Wilmington, Delaware, Incyte is a global biopharmaceutical company focused on discovering, developing, and commercializing proprietary therapeutics. The company’s portfolio includes first-in-class medicines and a robust pipeline targeting oncology, inflammation, and autoimmunity, with operations spanning North America, Europe, and Asia.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.